ARQT Financial Statements

Balance sheet, income statement, cash flow, and dividends for Arcutis Biotherapeutics Inc (ARQT).


$1.63B Market Cap.

As of 02/26/2025 5:00 PM ET (MRY) • Disclaimer

ARQT Market Cap. (MRY)


ARQT Shares Outstanding (MRY)


ARQT Assets (MRY)


Total Assets

$348.89M

Total Liabilities

$191.35M

Total Investments

$156.62M

ARQT Income (MRY)


Revenue

$196.54M

Net Income

-$140.04M

Operating Expense

$305.81M

ARQT Cash Flow (MRY)


CF Operations

-$112.16M

CF Investing

$28.82M

CF Financing

$66.20M

ARQT Dividends (MRY)


Period

Dividends

Yield %

Growth %

Payout Ratio

Coverage Ratio

2024

$0

0%

0%

0%

-

2023

$0

0%

0%

0%

-

2022

$0

0%

0%

0%

-

2021

$0

0%

0%

0%

-

2020

$0

0%

-

0%

-

ARQT Balance Sheet (MRY)


Metric

2024

2023

2022

2021

Total Assets

$348,889,000 (2.20%)

$341,365,000 (-24.02%)

$449,274,000 (10.08%)

$408,152,000 (36.84%)

Assets Current

$335,820,000 (1.63%)

$330,431,000 (-24.46%)

$437,406,000 (8.60%)

$402,773,000 (37.55%)

Assets Non-Current

$13,069,000 (19.53%)

$10,934,000 (-7.87%)

$11,868,000 (120.64%)

$5,379,000 (-1.18%)

Goodwill & Intangible Assets

$9,479,000 (47.24%)

$6,438,000 (-10.43%)

$7,188,000 (0%)

$0 (0%)

Shareholders Equity

$157,541,000 (77.68%)

$88,667,000 (-57.69%)

$209,581,000 (-29.59%)

$297,677,000 (10.00%)

Property Plant & Equipment Net

$2,994,000 (-23.23%)

$3,900,000 (-15.25%)

$4,602,000 (-13.19%)

$5,301,000 (-1.19%)

Cash & Equivalents

$71,952,000 (-19.45%)

$89,323,000 (62.78%)

$54,875,000 (-44.00%)

$97,991,000 (47.08%)

Accumulated Other Comprehensive Income

-$7,000 (-275.00%)

$4,000 (100.37%)

-$1,086,000 (-325.88%)

-$255,000 (-12650.00%)

Deferred Revenue

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Total Investments

$156,620,000 (-14.63%)

$183,463,000 (-48.46%)

$355,948,000 (22.48%)

$290,610,000 (32.48%)

Investments Current

$156,620,000 (-14.63%)

$183,463,000 (-48.46%)

$355,948,000 (22.48%)

$290,610,000 (32.48%)

Investments Non-Current

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Inventory

$14,526,000 (10.60%)

$13,134,000 (74.79%)

$7,514,000 (0%)

$0 (0%)

Trade & Non-Trade Receivables

$73,066,000 (183.12%)

$25,807,000 (205.12%)

$8,458,000 (0%)

$0 (0%)

Trade & Non-Trade Payables

$14,220,000 (18.58%)

$11,992,000 (35.86%)

$8,827,000 (20.05%)

$7,353,000 (2.98%)

Accumulated Retained Earnings (Deficit)

-$1,121,943,000 (-14.26%)

-$981,904,000 (-36.42%)

-$719,764,000 (-76.28%)

-$408,306,000 (-102.18%)

Tax Assets

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Tax Liabilities

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Total Debt

$110,585,000 (-46.30%)

$205,916,000 (1.67%)

$202,543,000 (161.15%)

$77,557,000 (1462.39%)

Debt Current

$820,000 (11.56%)

$735,000 (11.87%)

$657,000 (51.73%)

$433,000 (0%)

Debt Non-Current

$109,765,000 (-46.50%)

$205,181,000 (1.63%)

$201,886,000 (161.77%)

$77,124,000 (1453.67%)

Total Liabilities

$191,348,000 (-24.28%)

$252,698,000 (5.43%)

$239,693,000 (116.97%)

$110,475,000 (299.58%)

Liabilities Current

$81,013,000 (73.59%)

$46,668,000 (23.44%)

$37,807,000 (13.45%)

$33,326,000 (47.45%)

Liabilities Non-Current

$110,335,000 (-46.45%)

$206,030,000 (2.05%)

$201,886,000 (161.68%)

$77,149,000 (1428.91%)

ARQT Income Statement (MRY)


Metric

2024

2023

2022

2021

Revenues

$196,542,000 (229.74%)

$59,606,000 (1517.09%)

$3,686,000 (0%)

$0 (0%)

Cost of Revenue

$19,128,000 (283.56%)

$4,987,000 (561.41%)

$754,000 (0%)

$0 (0%)

Selling General & Administrative Expense

$229,391,000 (23.90%)

$185,145,000 (51.60%)

$122,124,000 (100.30%)

$60,971,000 (185.75%)

Research & Development Expense

$76,420,000 (-30.89%)

$110,575,000 (-39.39%)

$182,435,000 (25.33%)

$145,558,000 (26.23%)

Operating Expenses

$305,811,000 (3.41%)

$295,720,000 (-2.90%)

$304,559,000 (47.47%)

$206,529,000 (51.14%)

Interest Expense

$27,168,000 (-8.56%)

$29,712,000 (89.83%)

$15,652,000 (0%)

$0 (0%)

Income Tax Expense

$647,000 (-79.22%)

$3,113,000 (0%)

$0 (0%)

$0 (0%)

Net Loss Income from Discontinued Operations

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Consolidated Income

-$140,039,000 (46.58%)

-$262,140,000 (15.83%)

-$311,458,000 (-50.93%)

-$206,356,000 (-52.09%)

Net Income to Non-Controlling Interests

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Income

-$140,039,000 (46.58%)

-$262,140,000 (15.83%)

-$311,458,000 (-50.93%)

-$206,356,000 (-52.09%)

Preferred Dividends Income Statement Impact

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Income Common Stock

-$140,039,000 (46.58%)

-$262,140,000 (15.83%)

-$311,458,000 (-50.93%)

-$206,356,000 (-52.09%)

Weighted Average Shares

$120,957,633 (74.53%)

$69,305,487 (25.94%)

$55,032,265 (11.39%)

$49,405,575 (38.51%)

Weighted Average Shares Diluted

$120,957,633 (74.53%)

$69,305,487 (25.94%)

$55,032,265 (11.39%)

$49,405,575 (38.51%)

Earning Before Interest & Taxes (EBIT)

-$112,224,000 (51.06%)

-$229,315,000 (22.48%)

-$295,806,000 (-43.35%)

-$206,356,000 (-52.09%)

Gross Profit

$177,414,000 (224.82%)

$54,619,000 (1762.86%)

$2,932,000 (0%)

$0 (0%)

Operating Income

-$128,397,000 (46.75%)

-$241,101,000 (20.07%)

-$301,627,000 (-46.05%)

-$206,529,000 (-51.14%)

ARQT Cash Flow Statement (MRY)


Metric

2024

2023

2022

2021

Net Cash Flow from Investing

$28,820,000 (-84.01%)

$180,232,000 (306.69%)

-$87,199,000 (-14.81%)

-$75,953,000 (58.23%)

Net Cash Flow from Financing

$66,202,000 (-34.66%)

$101,323,000 (-66.43%)

$301,798,000 (7.04%)

$281,947,000 (-5.43%)

Net Cash Flow from Operations

-$112,158,000 (54.60%)

-$247,057,000 (4.14%)

-$257,715,000 (-47.58%)

-$174,627,000 (-54.49%)

Net Cash Flow / Change in Cash & Cash Equivalents

-$17,371,000 (-150.43%)

$34,448,000 (179.90%)

-$43,116,000 (-237.46%)

$31,367,000 (853.98%)

Net Cash Flow - Business Acquisitions and Disposals

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Cash Flow - Investment Acquisitions and Disposals

$33,963,000 (-81.20%)

$180,660,000 (382.65%)

-$63,916,000 (14.73%)

-$74,958,000 (58.70%)

Capital Expenditure

-$143,000 (66.59%)

-$428,000 (-28.53%)

-$333,000 (66.53%)

-$995,000 (-209.97%)

Issuance (Repayment) of Debt Securities

-$100,000,000 (0%)

$0 (0%)

$122,813,000 (69.75%)

$72,350,000 (0%)

Issuance (Purchase) of Equity Shares

$166,202,000 (64.03%)

$101,323,000 (-43.39%)

$178,985,000 (-14.61%)

$209,597,000 (-29.70%)

Payment of Dividends & Other Cash Distributions

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Effect of Exchange Rate Changes on Cash

-$235,000 (-370.00%)

-$50,000 (0%)

$0 (0%)

$0 (0%)

Share Based Compensation

$41,730,000 (7.52%)

$38,813,000 (18.76%)

$32,682,000 (36.79%)

$23,892,000 (200.79%)

Depreciation Amortization & Accretion

$3,007,000 (59.86%)

$1,881,000 (50.12%)

$1,253,000 (64.22%)

$763,000 (67.69%)

ARQT Financial Metrics (MRY)


Metric

2024

2023

2022

2021

Gross Margin

90.30% (-1.42%)

91.60% (15.22%)

79.50%

-

Profit Margin

-71.30% (83.79%)

-439.80% (94.80%)

-8449.80%

-

EBITDA Margin

-55.60% (85.43%)

-381.60% (95.22%)

-7991.10%

-

Return on Average Equity (ROAE)

-77.20% (73.82%)

-294.90% (-120.07%)

-134.00% (-147.69%)

-54.10% (10.87%)

Return on Average Assets (ROAA)

-32.80% (58.27%)

-78.60% (-2.34%)

-76.80% (-58.02%)

-48.60% (11.96%)

Return on Sales (ROS)

-57.10% (85.16%)

-384.70% (95.21%)

-8025.10%

-

Return on Invested Capital (ROIC)

-28.50% (50.95%)

-58.10% (13.54%)

-67.20% (4.00%)

-70.00% (42.58%)

Dividend Yield

0% (0%)

0% (0%)

0% (0%)

0% (0%)

Price to Earnings Ratio (P/E)

-12.01 (-1306.21%)

-0.85 (67.34%)

-2.62 (47.30%)

-4.96 (32.97%)

Price to Sales Ratio (P/S)

8.57 (128.25%)

3.76 (-98.30%)

220.97

-

Price to Book Ratio (P/B)

10.35 (201.02%)

3.44 (-20.10%)

4.3 (22.80%)

3.5 (-22.75%)

Debt to Equity Ratio (D/E)

1.22 (-57.37%)

2.85 (149.13%)

1.14 (208.36%)

0.37 (263.73%)

Earnings Per Share (EPS)

-1.16 (69.31%)

-3.78 (33.22%)

-5.66 (-35.41%)

-4.18 (-10.00%)

Sales Per Share (SPS)

1.63 (88.95%)

0.86 (1183.58%)

0.07 (0%)

0 (0%)

Free Cash Flow Per Share (FCFPS)

-0.93 (74.01%)

-3.57 (23.84%)

-4.69 (-31.90%)

-3.56 (-11.86%)

Book Value Per Share (BVPS)

1.3 (1.80%)

1.28 (-66.41%)

3.81 (-36.80%)

6.03 (-20.59%)

Tangible Assets Book Value Per Share (TABVPS)

2.81 (-41.94%)

4.83 (-39.84%)

8.03 (-2.76%)

8.26 (-1.21%)

Enterprise Value Over EBIT (EV/EBIT)

-15 (-650.00%)

-2 (33.33%)

-3 (40.00%)

-5 (44.44%)

Enterprise Value Over EBITDA (EV/EBITDA)

-15.59 (-783.51%)

-1.76 (49.06%)

-3.46 (28.41%)

-4.84 (44.79%)

Asset Turnover

0.46 (156.98%)

0.18 (1888.89%)

0.01 (0%)

0 (0%)

Current Ratio

4.14 (-41.45%)

7.08 (-38.80%)

11.57 (-4.28%)

12.09 (-6.72%)

Dividends

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Free Cash Flow (FCF)

-$112,301,000 (54.62%)

-$247,485,000 (4.09%)

-$258,048,000 (-46.93%)

-$175,622,000 (-54.93%)

Enterprise Value (EV)

$1,703,141,153 (324.17%)

$401,526,099 (-60.66%)

$1,020,631,795 (2.57%)

$995,034,066 (-16.06%)

Earnings Before Tax (EBT)

-$139,392,000 (46.19%)

-$259,027,000 (16.83%)

-$311,458,000 (-50.93%)

-$206,356,000 (-52.09%)

Earnings Before Interest Taxes & Depreciation Amortization (EBITDA)

-$109,217,000 (51.98%)

-$227,434,000 (22.79%)

-$294,553,000 (-43.27%)

-$205,593,000 (-52.04%)

Invested Capital

$297,030,000 (-26.63%)

$404,852,000 (-26.65%)

$551,947,000 (55.74%)

$354,392,000 (65.60%)

Working Capital

$254,807,000 (-10.20%)

$283,763,000 (-28.99%)

$399,599,000 (8.16%)

$369,447,000 (36.72%)

Tangible Asset Value

$339,410,000 (1.34%)

$334,927,000 (-24.24%)

$442,086,000 (8.31%)

$408,152,000 (36.84%)

Market Capitalization

$1,630,431,153 (434.82%)

$304,854,099 (-66.19%)

$901,731,795 (-13.55%)

$1,043,124,066 (-15.02%)

Average Equity

$181,387,750 (104.02%)

$88,906,000 (-61.74%)

$232,377,250 (-39.09%)

$381,538,500 (70.62%)

Average Assets

$427,385,750 (28.11%)

$333,617,750 (-17.77%)

$405,690,250 (-4.51%)

$424,867,000 (72.95%)

Invested Capital Average

$393,976,000 (-0.12%)

$394,461,250 (-10.43%)

$440,417,500 (49.40%)

$294,796,250 (164.84%)

Shares

117,044,591 (24.01%)

94,382,074 (54.91%)

60,927,824 (21.14%)

50,295,278 (15.26%)